This Section establishes requirements in addition to those
set forth at Section 22-30 of the School Code [105 ILCS 5] for a school nurse
or other trained school personnel to administer an undesignated
epinephrine auto-injector, an opioid antagonist, or asthma medication
to any person whom the school nurse or trained personnel in good faith
believes to be having an anaphylactic reaction, opioid overdose, or
acute asthma episode, respectively, while in school, while at a
school-sponsored activity, while under the supervision of school personnel, or
before or after normal school activities, such as while in before-school or
after-school care on school-operated property.
a) Definitions
For the purposes of this Section:
1) "Asthma medication" means quick-relief
asthma medication, including albuterol or other short-acting bronchodilators,
that is approved by the United States Food and Drug Administration for the
treatment of respiratory distress. "Asthma medication" includes medication
delivered through a device, including a metered dose inhaler with a reusable or
disposable spacer or a nebulizer with a mouthpiece or mask.
2) "Code" means the School Code [105 ILCS
5].
3) "School" means a school
district, public school or nonpublic school, as may be applicable.
4) "School nurse" has the meaning ascribed in
Section 22-30(a) of the Code.
b) Parental Notification
In addition to the provisions of Section 22-30(c) and (c-5)
of the Code, a school that has a standing protocol, as defined in Section 22-30
of the Code, to administer undesignated epinephrine, an opioid antagonist, or
asthma medication shall notify the parents or guardians of each student that
the school has instituted the standing protocol and that a student may be
administered any one or more of those drugs under the circumstances described
in Section 22-30(e-5), (e-10), or (e-15) of the Code.
1) The school shall provide the notification
of the standing protocol to the parents or guardian at the start of each school
year or, for students enrolling for the first time, at the time of enrollment.
The parent or guardian shall be asked to acknowledge the notification by
signing it and returning it to the school.
2) A parent's or guardian's failure to sign
and return the notification under subsection (b)(1) shall not preclude a school
nurse or other trained personnel from administering undesignated epinephrine,
an opioid antagonist, or asthma medication under the circumstances described in
Section 22-30(e-5), (e-10), or (e-15) of the Code.
c) Standing Protocol
1) A standing protocol for administering
undesignated epinephrine, an opioid antagonist, and/or asthma medication, as
applicable, shall be provided to the school nurse and trained personnel, as
well as kept with or near the epinephrine, opioid antagonist, or asthma
medication, as applicable.
2) The
standing protocol shall state the hours of the day, days of the week and the
school-sponsored activities during which the undesignated epinephrine, opioid
antagonist, or asthma medication, as applicable, will be available. A school is
not required to have a school nurse or trained personnel available at all times
nor at all school-sponsored activities to administer the epinephrine, opioid
antagonist, or asthma medication, as applicable.
3) The standing protocol shall provide that
the undesignated epinephrine, opioid antagonist, or asthma medication, as
applicable, be stored in and available daily at one or more designated, secure
locations. For the purposes of this Section, "secure location" means an
unlocked location that is inaccessible to students and/or is visually monitored
by an adult during the normal school day under routine circumstances.
4) The standing protocol shall include a
written order for the undesignated epinephrine, opioid antagonist, or asthma
medication that meets the requirements of Section 22-30(f) of the Code. (See
Section 22-30(f) of the Code.)
d) Notification of Administration of
Undesignated Epinephrine, Opioid Antagonist, or Asthma Medication
Any school whose school nurse or trained personnel
administered undesignated epinephrine, opioid antagonist, or asthma medication,
as applicable, shall meet the notification requirements of Section 22-30(f-5)
and (f-10) of the Code.
e)
Personnel Training
Only trained personnel or a school nurse shall administer
undesignated epinephrine, opioid antagonist, or asthma medication, as
applicable.
1) Certification courses
required under Section 22-30(g) of the Code in cardiopulmonary resuscitation
(CPR) and the use of an automated external defibrillator (AED) shall be
conducted by a trainer who is certified in CPR/AED by the American Heart
Association, American Red Cross or similar certifying body. Trained personnel
shall renew any certification issued in accordance with the requirements of the
certifying body and present the certification to his or her school.
2) A school administrator or a school nurse
shall be available to answer questions from training participants if the
training for administering undesignated epinephrine, opioid antagonist, or
asthma medication is presented via a webinar or online format or through a
video supplied by an epinephrine, opioid antagonist, or asthma medication
manufacturer. Training provided in one of the formats listed in this subsection
(e)(2) shall not be considered complete unless an opportunity for questions is
provided.
3) In addition to the
curricular content listed in Section 22-30(h) of the Code, anaphylaxis training
also shall include information about:
A) where
the undesignated epinephrine medications are stored and how to access
them;
B) the method by which the
school nurse or trained personnel will be notified of an incident that could
require the administration of undesignated epinephrine;
C) the school's written plan to prevent
exposure to allergens;
D) the
process for administering the specific undesignated epinephrine device
identified in the standing order; and
E) the restrictions, if any, on the school
personnel who may administer epinephrine. Use of pre-filled or user-filled
syringes containing epinephrine are limited to a nurse holding an RN or LPN
license or the person experiencing the reaction.
4) In addition to the curricular content
listed in Section 22-30(h-5) of the Code, opioid antagonist training also shall
meet the requirements of Section 5-23 of the Alcoholism and Other Drug Abuse
and Dependency Act [20 ILCS 301] and training requirements set forth at 77 Ill.
Adm. Code
2060 (Alcoholism and Substance Abuse Treatment and Intervention
Licenses) and include information about:
A)
where the opioid antagonist is stored and how to access the drug;
B) the method by which the school nurse or
trained personnel will be notified of an incident that could require the
administration of any opioid antagonist; and
C) the process for administering the specific
opioid antagonist identified in the standing order.
5) In addition to the curricular content
listed in Section 22-30(h-10) of the Code, asthma medication training also
shall include the following information:
A)
where the undesignated medications to treat respiratory distress are stored and
how to access them;
B) the method
by which the school nurse or trained personnel will be notified of an incident
that could require the administration of medication for acute respiratory
distress;
C) the school's written
Asthma Episode Emergency Response Protocol;
D) assurance that the personnel agreeing to
perform in the role of "trained personnel" has completed training on asthma;
and
E) the process for
administering the specific undesignated asthma medication and delivery device
identified in the standing order.
6) A school nurse or physician with knowledge
of allergies and anaphylaxis and CPR and AED certification who possesses skill
in administering or demonstrating the use of epinephrine injector devices shall
certify by written signature that the personnel being trained passed the test
required under Section 22-30(h)(7) of the Code.
7) An individual familiar with the use of an
opioid antagonist who has CPR and AED certification (e.g., healthcare provider,
police officer, paramedic) shall certify by written signature that the
personnel being trained passed the test required under Section 22-30(h-5)(8) of
the Code.
8) A school
administrator, school nurse or physician, with knowledge of asthma and symptoms
of respiratory distress, who holds CPR and AED certifications, and who
possesses skill in administering or demonstrating the use of asthma medications
for acute respiratory distress and delivery device, shall certify by written
signature that the personnel being trained passed the test required by Section
22-30(h)(10) of the Code.
9) Each
statement of certification issued under subsection (e)(6) or (e)(7) shall be
maintained by the school in accordance with Section 22-30(g) of the
Code.
10) The names of trained
personnel shall be provided to the school nurse and school administrator,
indicating whether the person received training specific to anaphylaxis, opioid
antagonist, and/or asthma medication.
f) Reporting
Each school shall submit a report regarding the
administration of undesignated epinephrine, opioid antagonist, or undesignated
asthma medication electronically in a format prescribed by the State
Superintendent of Education within the timeline specified in Section 22-30(i),
(i-5), or (i-10), respectively, of the Code.
g) Allergen Reduction Plan
Each school shall develop a written plan to reduce the risk
of accidental exposure to allergens that addresses, at a minimum, lunchroom
safeguards, classroom food policies, and identification of areas of the
playground that are known concerns, such as those with insect colonies. A
separate plan is not required if the school has addressed reducing the risk of
accidental exposure to allergens in the plan adopted pursuant to Section
2-3.149(b) of the Code.
h)
In accordance with Section 22-30(h) of the Code, the State Superintendent of
Education shall post on the agency's website, by January 1, 2019, a list of
resource materials about how to recognize and respond to
anaphylaxis, opioid overdose, or respiratory
distress.
